Literature DB >> 20410820

Transintestinal cholesterol efflux.

Astrid E van der Velde1, Gemma Brufau, Albert K Groen.   

Abstract

PURPOSE OF REVIEW: Regulation of cholesterol homeostasis is a complex interplay of a multitude of metabolic pathways situated in different organs. The liver plays a central role and has received most attention of the research community. In this review, we discuss recent progress in the understanding of the emerging role of the intestine in cholesterol transport. RECENT
FINDINGS: In recent years, insight in the transport systems that mediate intestinal cholesterol excretion has deepened considerably. Evidence is emerging that the proximal part of the small intestine is able to secrete cholesterol actively, a pathway called transintestinal cholesterol efflux (TICE). In mice, TICE accounts for up to 70% of fecal neutral sterol excretion.
SUMMARY: The small intestine plays a significant role in the regulation of body cholesterol homeostasis. Active processes control both absorption and excretion of the sterol and the pathways involved are being elucidated. TICE might provide an attractive target for therapy aiming at reduction of atherosclerosis.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20410820     DOI: 10.1097/MOL.0b013e3283395e45

Source DB:  PubMed          Journal:  Curr Opin Lipidol        ISSN: 0957-9672            Impact factor:   4.776


  49 in total

Review 1.  Crosstalk between reverse cholesterol transport and innate immunity.

Authors:  Kathleen M Azzam; Michael B Fessler
Journal:  Trends Endocrinol Metab       Date:  2012-03-10       Impact factor: 12.015

2.  Location, location, location...again.

Authors:  Shailendra B Patel
Journal:  J Lipid Res       Date:  2011-01-04       Impact factor: 5.922

Review 3.  Therapies targeting exogenous cholesterol uptake: new insights and controversies.

Authors:  Michael H Davidson
Journal:  Curr Atheroscler Rep       Date:  2011-02       Impact factor: 5.113

Review 4.  A new model of reverse cholesterol transport: enTICEing strategies to stimulate intestinal cholesterol excretion.

Authors:  Ryan E Temel; J Mark Brown
Journal:  Trends Pharmacol Sci       Date:  2015-04-27       Impact factor: 14.819

5.  Intestine-Specific Overexpression of LDLR Enhances Cholesterol Excretion and Induces Metabolic Changes in Male Mice.

Authors:  Luca Meoli; Danny Ben-Zvi; Courtney Panciotti; Stephanie Kvas; Palmenia Pizarro; Rodrigo Munoz; Nicholas Stylopoulos
Journal:  Endocrinology       Date:  2019-04-01       Impact factor: 4.736

Review 6.  Experimental models for the investigation of high-density lipoprotein-mediated cholesterol efflux.

Authors:  Carlos G Santos-Gallego; Chiara Giannarelli; Juan José Badimón
Journal:  Curr Atheroscler Rep       Date:  2011-06       Impact factor: 5.113

7.  Lactobacillus acidophilus ATCC 4356 prevents atherosclerosis via inhibition of intestinal cholesterol absorption in apolipoprotein E-knockout mice.

Authors:  Ying Huang; Jinfeng Wang; Guihua Quan; Xiaojun Wang; Longfei Yang; Lili Zhong
Journal:  Appl Environ Microbiol       Date:  2014-09-26       Impact factor: 4.792

8.  Overview and introduction: thematic review series on intestinal lipid metabolism.

Authors:  Nicholas O Davidson
Journal:  J Lipid Res       Date:  2015-02-15       Impact factor: 5.922

9.  Investigating Sitosterolemia to Understand Lipid Physiology.

Authors:  T Hang Nghiem-Rao; Shailendra B Patel
Journal:  Clin Lipidol       Date:  2017-01-18

10.  Activation of intestinal peroxisome proliferator-activated receptor-α increases high-density lipoprotein production.

Authors:  Sophie Colin; Olivier Briand; Véronique Touche; Kristiaan Wouters; Morgane Baron; François Pattou; Rémy Hanf; Anne Tailleux; Giulia Chinetti; Bart Staels; Sophie Lestavel
Journal:  Eur Heart J       Date:  2012-07-26       Impact factor: 29.983

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.